Community-based scheduled screening and treatment of malaria in pregnancy for improved maternal and infant health in The Gambia, Burkina Faso and Benin: study protocol for a randomized controlled trial
Tóm tắt
In sub-Saharan Africa, malaria continues to cause over 10,000 maternal deaths and 75,000 to 200,000 infant deaths. Successful control of malaria in pregnancy could save lives of mothers and babies and is an essential part of antenatal care in endemic areas. The primary objective is to determine the protective efficacy of community-scheduled screening and treatment (CSST) using community health workers (CHW) against the primary outcome of prevalence of placental malaria. The secondary objectives are to determine the protective efficacy of CSST on maternal anaemia, maternal peripheral infection, low birth weight, selection of sulfadoxine-pyrimethamine (SP) resistance markers, and on antenatal clinic (ANC) attendance and coverage of intermittent preventive treatment during pregnancy (IPTp-SP). This is a multi-centre cluster-randomised controlled trial involving three countries with varying malaria endemicity; low (The Gambia) versus high transmission (Burkina Faso and Benin), and varying degrees of SP resistance (high in Benin and moderate in Gambia and Burkina Faso). CHW and their related catchment population who are randomised into the intervention arm will receive specific training on community-based case management of malaria in pregnancy. All women in both study arms will be enrolled at their first ANC visits in their second trimester where they will receive their first dose of IPTp-SP. Thereafter, CHW in the intervention arm will perform scheduled monthly screening and treatment in the womens homes. At time of delivery, a placental biopsy will be collected from all women to determine placental malaria. At each contact point, filter paper and blood slides will be collected for detection of malaria infection and SP resistance markers. To reach successful global malaria control, there is an urgent need to access those at greatest risk of malaria infection. The project is designed to develop a low-cost intervention in pregnant women which will have an immediate impact on the malaria burden in resource-limited countries. This will be done by adding to the standard IPTp-SP delivered through the health facilities: an “extension” strategy to the communities in rural areas thus bringing health services closer to where women live. Current Controlled Trials:
ISRCTN37259296
(5 July 2013), and clinicaltrials.gov:
NCT01941264
(10 September 2013).
Tài liệu tham khảo
World Health Organization: World Malaria Report. 2013,http://www.who.int/malaria/publications/world_malaria_report_2013/en/,
ter Kuile FO, van Eijk AM, Filler SJ: Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. JAMA. 2007, 297: 2603-2616. 10.1001/jama.297.23.2603.
Menendez C, D’Alessandro U, ter Kuile FO: Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis. 2007, 7: 126-135. 10.1016/S1473-3099(07)70024-5.
Uddenfeldt Wort U, Hastings I, Bergstrom S, Massawe S, Lipingu C, Brabin BJ: Increased postpartum blood loss in pregnancies associated with placental malaria. Int J Gynaecol Obstet. 2007, 96: 171-175. 10.1016/j.ijgo.2006.11.023.
Grietens KP, Gies S, Coulibaly SO, Ky C, Somda J, Toomer E, Muela Ribera J, D’Alessandro U: Bottlenecks for high coverage of intermittent preventive treatment in pregnancy: the case of adolescent pregnancies in rural Burkina Faso. PLoS One. 2010, 5: e12013-10.1371/journal.pone.0012013.
Mount AM, Mwapasa V, Elliott SR, Beeson JG, Tadesse E, Lema VM, Molyneux ME, Meshnick SR, Rogerson SJ: Impairment of humoral immunity to Plasmodium falciparum malaria in pregnancy by HIV infection. Lancet. 2004, 363: 1860-1867. 10.1016/S0140-6736(04)16354-X.
Mens PF, Bojtor EC, Schallig HD: Molecular interactions in the placenta during malaria infection. Eur J Obstet Gynecol Reprod Biol. 2010, 152: 126-132. 10.1016/j.ejogrb.2010.05.013.
Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO: Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. PLoS Med. 2010, 7: e1000221-10.1371/journal.pmed.1000221.
Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD: Epidemiology and burden of malaria in pregnancy. Lancet Infect Dis. 2007, 7: 93-104. 10.1016/S1473-3099(07)70021-X.
Mutabingwa TK, Bolla MC, Li JL, Domingo GJ, Li X, Fried M, Duffy PE: Maternal malaria and gravidity interact to modify infant susceptibility to malaria. PLoS Med. 2005, 2: e407-10.1371/journal.pmed.0020407.
Schwarz NG, Adegnika AA, Breitling LP, Gabor J, Agnandji ST, Newman RD, Lell B, Issifou S, Yazdanbakhsh M, Luty AJ, Kremsner PG, Grobusch MP: Placental malaria increases malaria risk in the first 30 months of life. Clin Infect Dis. 2008, 47: 1017-1025. 10.1086/591968.
Malhotra I, Dent A, Mungai P, Wamachi A, Ouma JH, Narum DL, Muchiri E, Tisch DJ, King CL: Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. PLoS Med. 2009, 6: e1000116-10.1371/journal.pmed.1000116.
World Health Organization: World Malaria Report. 2011,http://www.who.int/malaria/world_malaria_report_2011/en/,
Sexton AR: Best practices for an insecticide-treated bed net distribution programme in sub-Saharan eastern Africa. Malar J. 2011, 10: 157-10.1186/1475-2875-10-157.
World Health Organization: Intermittent Preventive Treatment of Malaria in Pregnancy using Sulfadoxine-Pyrimethamine (IPTp-SP): update WHO Policy Recommendations (October 2012). 2012,http://www.who.int/malaria/iptp_sp_updated_policy_recommendation_en_102012.pdf,
van Eijk AM, Hill J, Larsen DA, Webster J, Steketee RW, Eisele TP, Ter Kuile FO: Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009–11. Lancet Infect Dis. 2013, 13: 1029-1042. 10.1016/S1473-3099(13)70199-3.
Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE: Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011, 53: 224-230. 10.1093/cid/cir376.
Greenwood B, Bojang K, Tagbor H, Pagnoni F: Combining community case management and intermittent preventive treatment for malaria. Trends Parasitol. 2011, 27: 477-480. 10.1016/j.pt.2011.06.005.
Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P: Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Malar J. 2011, 10: 196-10.1186/1475-2875-10-196.
Tinto H, Ouedraogo JB, Zongo I, van Overmeir C, van Marck E, Guiguemde TR, D’Alessandro U: Sulfadoxine-pyrimethamine efficacy and selection of Plasmodium falciparum DHFR mutations in Burkina Faso before its introduction as intermittent preventive treatment for pregnant women. Am J Trop Med Hyg. 2007, 76: 608-613.
National Malaria Control Program MoHaSW, The Gambia: Guidelines for the Managment of Malaria. 2010
Ministry of Health BF: Directives Nationales pour la prise en charge du Paludisme dans les Formations Sanitaires du Burkina Faso. 2012
Ministère de la santé Benin PNdLclP: Directives Nationales de prise en charge des cas de paludisme. 2011
Ballard JL, Khoury JC, Wedig K, Wang L, Eilers-Walsman BL, Lipp R: New Ballard Score, expanded to include extremely premature infants. J Pediatr. 1991, 119: 417-423. 10.1016/S0022-3476(05)82056-6.
Bulmer JN, Rasheed FN, Francis N, Morrison L, Greenwood BM: Placental malaria. I. Pathological classification. Histopathology. 1993, 22: 211-218. 10.1111/j.1365-2559.1993.tb00110.x.
World Health Organization: Guidelines for the Treatment of Malaria. 2010,http://www.who.int/malaria/publications/atoz/9789241547925/en/, 2,
Manyando C, Kayentao K, D’Alessandro U, Okafor HU, Juma E, Hamed K: A systematic review of the safety and efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria during pregnancy. Malar J. 2012, 11: 141-10.1186/1475-2875-11-141.
Hayes RJ, Bennett S: Simple sample size calculation for cluster-randomized trials. Int J Epidemiol. 1999, 28: 319-326. 10.1093/ije/28.2.319.
Tagbor H, Bruce J, Agbo M, Greenwood B, Chandramohan D: Intermittent screening and treatment versus intermittent preventive treatment of malaria in pregnancy: a randomised controlled non-inferiority trial. PLoS One. 2010, 5: e14425-10.1371/journal.pone.0014425.
Hill J, Hoyt J, van Eijk AM, D’Mello-Guyett L, Ter Kuile FO, Steketee R, Smith H, Webster J: Factors affecting the delivery, access, and use of interventions to prevent malaria in pregnancy in sub-Saharan Africa: a systematic review and meta-analysis. PLoS Med. 2013, 10: e1001488-10.1371/journal.pmed.1001488.
Achadi E, Scott S, Pambudi ES, Makowiecka K, Marshall T, Adisasmita A, Deviany PE, Ronsmans C: Midwifery provision and uptake of maternity care in Indonesia. Trop Med Int Health. 2007, 12: 1490-1497. 10.1111/j.1365-3156.2007.01957.x.
Hounton S, Chapman G, Menten J, De Brouwere V, Ensor T, Sombi I, Meda N, Ronsmans C: Accessibility and utilisation of maternity care within a Skilled Care Initiative in rural Burkina Faso. Trop Med Int Health. 2008, 13 (suppl I): 44-52.
Thaddeus S, Maine D: Too far to walk: maternal mortality in context. Soc Sci Med. 1994, 38: 1091-1110. 10.1016/0277-9536(94)90226-7.
Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Duffy PE: Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A. 2009, 106: 9027-9032. 10.1073/pnas.0901415106.